Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine
26. Mai 2021 08:00 ET
|
Senti Bio; BlueRock Therapeutics LP
CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- BlueRock Therapeutics LP, a leading engineered cell therapy company and a wholly-owned and independently operated...